A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
Graux, Carlos, Sonet, Anne, Maertens, Johan, Duyster, Justus, Greiner, Jochen, Chalandon, Yves, Martinelli, Giovanni, Hess, Dagmar, Heim, Dominik, Giles, Francis J, Kelly, Kevin R, Gianella-Borradori, Athos, Longerey, Blandine, Asatiani, Ekaterine, Rejeb, Narmyn, Ottmann, Oliver G
Published in Leukemia research (01.09.2013)
Published in Leukemia research (01.09.2013)
Get full text
Journal Article
Abstract C195: Phase I study of 2 dosing regimens of AS703569, an oral Aurora kinase inhibitor, in patients with solid tumors
Mita, Monica, Gordon, Michael, Gianella-Borradori, Athos, Longerey, Blandine, Rejeb, Narmyn, Mendelson, David
Published in Molecular cancer therapeutics (10.12.2009)
Published in Molecular cancer therapeutics (10.12.2009)
Get full text
Journal Article
Abstract 4433: A Phase I study of two dosing regimens of oral AS703569, an inhibitor of aurora kinase and other kinases, in patients with hematologic malignancies
Graux, Carlos, Sonet, Anne, Maertens, Johan, Duyster, Justus, Greiner, Jochen, Chalandon, Yves, Martinelli, Giovanni, Hess, Dagmar, Heim, Dominik, Giles, Frank J., Gianella-Borradori, Athos, Longerey, Blandine, Rejeb, Narmyn, Ottmann, Oliver G.
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies
Sonet, Anne, Graux, Carlos, Maertens, Johan, Hartog, Christine-Maria, Duyster, Justus, Götze, Katharina, Greiner, Jochen, Hütter, Marie-Luise, Gratwohl, Alois, Heim, Dominik, Hess, Dagmar, Chalandon, Yves, Gianella-Borradori, Athos, Rejeb, Narmyn, Ottmann, Oliver
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article